New England Journal of Medicine publishes two related pieces focused on tranexamic acid, a drug used to reduce bleeding and transfusion needs during surgery. One article describes a hospital policy approach to using tranexamic acid in major noncardiac surgical procedures, aiming to lower the number of transfusions required. The other item presents commentary that supports broader surgical use of tranexamic acid, emphasizing the potential benefits of wider adoption in appropriate settings.
Taken together, the publications present both an implementation-focused perspective and an advocacy-oriented viewpoint on surgical tranexamic acid. The hospital-policy study reports outcomes associated with routine or policy-guided administration in major noncardiac operations, while the accompanying discussion argues for greater use of the medication in surgical practice.
Across both pieces, the central theme is the role of tranexamic acid in reducing transfusion exposure during major surgery. The materials appear in an ahead-of-print format, indicating the research and perspectives are newly released and not yet fully integrated into the journal’s later issue structure.
